Chen et al. reported that aberrant amplification of FAM83A promotes pancreatic cancer stem cell-like traits by activating the TGF-β and Wnt signaling pathways, resulting in poorer clinical outcomes in patients with cancer 9. The gene discussed is SACK1A; the disease is pancreatic neoplasm.